Cargando…

The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States

Background Although the sudden coronavirus disease 2019 (COVID-19) pandemic would have significantly influenced financial relationships between the healthcare industry and gastroenterologists and hepatologists, little is known about the trend in financial relations in the United States. This study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murayama, Anju, Kamamoto, Sae, Saito, Hiroaki, Tanimoto, Tetsuya, Ozaki, Akihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Gastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849032/ https://www.ncbi.nlm.nih.gov/pubmed/36686074 http://dx.doi.org/10.7759/cureus.32711

Ejemplares similares

Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic
por: Murayama, Anju, et al.
Publicado: (2022)

Research and Nonresearch Industry Payments for COVID-19 mRNA Vaccines in the United States
por: Murayama, Anju, et al.
Publicado: (2023)

Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic
por: Murayama, Anju, et al.
Publicado: (2022)

Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 2020
por: Murayama, Anju, et al.
Publicado: (2022)

Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
por: Murayama, Anju, et al.
Publicado: (2023)

Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
por: Kusumi, Eiji, et al.
Publicado: (2022)

Pharmaceutical Payments to Japanese Board‐Certified Head and Neck Surgeons Between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Gastroenterologists, Hepatologists, COVID-19 and the Use of Acetaminophen
por: Rodríguez-Morales, Alfonso J., et al.
Publicado: (2020)

Factors influencing the participation of gastroenterologists and hepatologists in clinical research
por: Dev, Anouk T, et al.
Publicado: (2008)

Advancing health equity: The Association of Black Gastroenterologists and Hepatologists
por: White, Pascale M., et al.
Publicado: (2021)

Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan
por: Murayama, Anju, et al.
Publicado: (2020)

Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021
por: Shigeta, Haruki, et al.
Publicado: (2023)

Moving Toward Impact: An Introduction to Implementation Science for Gastroenterologists and Hepatologists
por: Rogal, Shari S., et al.
Publicado: (2020)

Barriers to research productivity among gastroenterologists and hepatologists in Saudi Arabia
por: AlSardi, Mais, et al.
Publicado: (2020)

Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019
por: Kamamoto, Sae, et al.
Publicado: (2023)

The Perceived Ability of Gastroenterologists, Hepatologists and Surgeons Can Bias Medical Decision Making
por: Cucchetti, Alessandro, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Gastrointestinal Toxicity: The Opinion of a Gastroenterologist
por: Macovei Oprescu, Anca, et al.
Publicado: (2021)

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan
por: Sawano, Toyoaki, et al.
Publicado: (2019)

Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016
por: Shimada, Yuki, et al.
Publicado: (2019)

Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort study
por: Kaplan, David E., et al.
Publicado: (2018)

Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
por: Saito, Hiroaki, et al.
Publicado: (2019)

Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians
por: Murayama, Anju, et al.
Publicado: (2022)

Coronavirus disease 2019 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies
por: Murayama, Anju, et al.
Publicado: (2021)

Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan
por: Hashimoto, Takanao, et al.
Publicado: (2022)

Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension
por: Senoo, Yuki, et al.
Publicado: (2021)

Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey
por: Rinella, Mary, et al.
Publicado: (2022)

How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
por: Ozaki, Akihiko, et al.
Publicado: (2022)

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
por: Ozaki, Akihiko, et al.
Publicado: (2019)

Industry Payments to Nephrologists in the United States
por: Pakanati, Abhinandan R, et al.
Publicado: (2021)

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Red Blood Cell Transfusions and Iron Therapy for Patients Presenting with Acute Upper Gastrointestinal Bleeding: A Survey of Canadian Gastroenterologists and Hepatologists
por: Fortinsky, Kyle J., et al.
Publicado: (2016)

Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.
por: Kosaka, Makoto, et al.
Publicado: (2023)

Think Outside the Box: A Rare Presentation of Schistosomiasis in the United States
por: Anjum, Humayun, et al.
Publicado: (2022)

Epidemiology and Outcomes of Hospitalized Inflammatory Bowel Disease Patients with Asthma in the United States
por: Khneizer, Gebran, et al.
Publicado: (2019)

Observational study of financial and non-financial conflicts of interest among the Japanese government advisory board members concerning coronavirus disease 2019
por: Mamada, Hanano, et al.
Publicado: (2023)

Trends of Industry Payments in Neurology Subspecialties
por: Nalleballe, Krishna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gk9dkvmran2tflrjvd2vopf3u3